@vancouverislandhiker Testicular cancer appeared in neither the best funded or worst funded list. And the relative numbers were not per 100K, but "cancer burden" which (I believe) refers to the total number of cases and to the severity.

Both in absolute and relative terms, prostate cancer, breast cancer, and leukemia were far and way the best funded, taking over 50% of all cancer research funding. That's probably a big part of the reason that we have so many new treatment options these days, and that even stage 4 prostate cancer is on the verge of becoming a chronic rather than fatal disease (as the Scientific American article discussed last year).

Because of the huge research resources devoted over the past couple of decades, prostate cancer isn't quite defeated yet, but it's close to being caged, which is the next best thing. By comparison, female reproductive-system cancers have a long way to go, and and still suffer from tragically-high mortality rates. I hope some day soon they get the same research benefits that we're experiencing now.